We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$546M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$307M
3
AMTD
TD Ameritrade Holding Corp
AMTD
+$260M
4
ETFC
E*Trade Financial Corporation
ETFC
+$205M
5
BAC icon
Bank of America
BAC
+$196M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STR
4151
DELISTED
Sitio Royalties
STR
$34K ﹤0.01%
+2,720
New +$27.6K
YJ
4152
Yunji
YJ
$6.06M
$34K ﹤0.01%
+458
New +$39.7K
OVID icon
4153
Ovid Therapeutics
OVID
$495M
$33K ﹤0.01%
+14,568
New +$67.9K
ENZ
4154
DELISTED
Enzo Biochem, Inc.
ENZ
$32K ﹤0.01%
12,664
-254
-2% -$553
DHX icon
4155
DHI Group
DHX
$179M
$31K ﹤0.01%
+14,033
New +$28.8K
TLPH icon
4156
Talphera
TLPH
$74.2M
$31K ﹤0.01%
+1,236
New +$37.8K
BURU.WS
4157
CALL
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$31K ﹤0.01%
+21,900
New +$22.9K
SBBP
4158
DELISTED
Strongbridge Biopharma plc.
SBBP
$30K ﹤0.01%
+12,408
New +$29.9K
XCUR icon
4159
Exicure
XCUR
$8.6M
$29K ﹤0.01%
+109
New +$27.3K
ADMA icon
4160
ADMA Biologics
ADMA
$2.25B
$28K ﹤0.01%
+14,634
New +$30.8K
VBIV
4161
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$28K ﹤0.01%
+333
New +$28.4K
ABEO icon
4162
Abeona Therapeutics
ABEO
$393M
$27K ﹤0.01%
+687
New +$23.4K
MLSS icon
4163
Milestone Scientific
MLSS
$41.1M
$27K ﹤0.01%
+12,733
New +$22.4K
AVTX icon
4164
Avalo Therapeutics
AVTX
$1B
$26K ﹤0.01%
+4
New +$27.8K
BORR
4165
Borr Drilling
BORR
$1.2B
$26K ﹤0.01%
16,009
-7,367
-32% -$10.1K
JFU
4166
9F Inc
JFU
$29M
$26K ﹤0.01%
+1,241
New +$32.1K
LCTX icon
4167
Lineage Cell Therapeutics
LCTX
$282M
$26K ﹤0.01%
+15,000
New +$21K
VTVT icon
4168
vTv Therapeutics
VTVT
$136M
$24K ﹤0.01%
+330
New +$25.3K
TYME
4169
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$24K ﹤0.01%
+19,100
New +$19.5K
MBII
4170
DELISTED
Marrone Bio Innovations, Inc.
MBII
$24K ﹤0.01%
+19,169
New +$22.9K
GALT icon
4171
Galectin Therapeutics
GALT
$212M
$23K ﹤0.01%
+10,210
New +$26.8K
PAVM icon
4172
PAVmed
PAVM
$35.4M
$23K ﹤0.01%
+24
New +$20.5K
VSTM icon
4173
CALL
Verastem
VSTM
$519M
$22K ﹤0.01%
+833
New +$16.7K
CRBP icon
4174
Corbus Pharmaceuticals
CRBP
$180M
$21K ﹤0.01%
578
-23,953
-98% -$896K
IZEA icon
4175
IZEA Worldwide
IZEA
$59M
$21K ﹤0.01%
+2,925
New +$11.2K
165 166
167
168 169

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.